Galectin-9 protects humanized-ACE2 immunocompetent mice from SARS-CoV-2 infection.

Yeung ST, Premeaux TA, Du L, Niki T, Pillai SK, Khanna KM, Ndhlovu LC. Galectin-9 protects humanized-ACE2 immunocompetent mice from SARS-CoV-2 infection. Front Immunol. 2022; 13:1011185.

View in: PubMed

subject areas

Animals
Galectins
Humans
Mice
Mice, Transgenic

authors with profiles

Lishomwa Ndhlovu, MD PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support